Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: A prospective cohort study

Breast Cancer Research and Treatment

Volumn 125, Issue 3, 2011, Pages 869-878

  Prieto Alhambra, Daniel ^a,c,d,e,f   Javaid, M Kassim ^c   Servitja, Sonia ^a,b   Arden, Nigel K ^c   Martinez García, Maria ^a,b   Diez Perez, Adolfo ^a,b   Albanell, Joan ^a,b   Tusquets, Ignasi ^a,b   Nogues, Xavier ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d INSTITUT CATALÀ DE LA SALUT   (Spain)

^e Research Institute University Primary Care IDIAP Jordi Gol   (Spain)

^f NONE   (Spain)

Author keywords

Aromatase inhibitors; Arthralgia; Breast neoplasms; Cohort studies; Vitamin D

Indexed keywords

ALENDRONIC ACID; AMINO TERMINAL TELOPEPTIDE; ANASTROZOLE; AROMATASE INHIBITOR; BISPHOSPHONIC ACID DERIVATIVE; CALCIFEDIOL; CALCIUM; COLECALCIFEROL; EXEMESTANE; IBANDRONIC ACID; LETROZOLE; RISEDRONIC ACID; TAMOXIFEN; VITAMIN D;

ADULT; AGE DISTRIBUTION; ARTHRALGIA; ARTICLE; BODY MASS; BREAST CANCER; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FEMALE; HUMAN; INCIDENCE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; OSTEOPENIA; OSTEOPOROSIS; PAIN ASSESSMENT; PRIORITY JOURNAL; RISK REDUCTION; VISUAL ANALOG SCALE;

AGED; AROMATASE INHIBITORS; ARTHRALGIA; BONE DENSITY; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; MODELS, STATISTICAL; PROSPECTIVE STUDIES; SPINE; TREATMENT OUTCOME; VITAMIN D;

EID: 79151476000     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1075-9     Document Type: Article

References (55)

1. RC Coombes LS Kilburn CF Snowdon R Paridaens RE Coleman SE Jones J Jassem CJ Van de Velde T Delozier I Alvarez L Del Mastro O Ortmann K Diedrich AS Coates E Bajetta SB Holmberg D Dodwell E Mickiewicz J Andersen PE Lonning G Cocconi J Forbes M Castiglione N Stuart A Stewart LJ Fallowfield G Bertelli E Hall RG Bogle M Carpentieri E Colajori M Subar E Ireland JM Bliss 2007 Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (intergroup exemestane study): a randomised controlled trial Lancet 369 9561 559 570 10.1016/S0140-6736(07)60200-1 1:CAS:528:DC%2BD2sXhvVGgsro%3D 10.1016/S0140-6736(07)60200-1 17307102
2. R Eastell RA Hannon J Cuzick M Dowsett G Clack JE Adams 2006 Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the anastrozole, tamoxifen, alone or in combination (atac) trial (18233230) J Bone Miner Res 21 8 1215 1223 10.1359/jbmr.060508 1:CAS:528:DC%2BD28XotlKrsL8%3D 10.1359/jbmr.060508 16869719 (Pubitemid 44128334)
3. JA Cauley AZ Lacroix L Wu M Horwitz ME Danielson DC Bauer JS Lee RD Jackson JA Robbins C Wu FZ Stanczyk MS LeBoff J Wactawski-Wende G Sarto J Ockene SR Cummings 2008 Serum 25 HydroxyVitamin D concentrations and the risk of hip fractures: the women's health initiative Ann Intern Med 149 4 242 250 18711154
4. A Howell J Cuzick M Baum A Buzdar M Dowsett JF Forbes G Hoctin-Boes J Houghton GY Locker JS Tobias 2005 Results of the atac (arimidex, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for breast cancer Lancet 365 9453 60 62 10.1016/S0140-6736(04)17666-6 1:STN:280:DC%2BD2M%2FhsVartA%3D%3D 10.1016/S0140-6736(04)17666-6 15639680 (Pubitemid 40082147)
5. DT Felson SR Cummings 2005 Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation Arthritis Rheum 52 9 2594 2598 10.1002/art.21364 1:CAS:528:DC%2BD2MXhtFeltrvK 10.1002/art.21364 16142740 (Pubitemid 41369086)
6. H Mouridsen A Giobbie-Hurder A Goldhirsch B Thurlimann R Paridaens I Smith L Mauriac JF Forbes KN Price MM Regan RD Gelber AS Coates 2009 Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer N Engl J Med 361 8 766 776 10.1056/NEJMoa0810818 1:CAS:528:DC%2BD1MXhtVWls7fM 10.1056/NEJMoa0810818 19692688
7. M Baum A Buzdar J Cuzick J Forbes J Houghton A Howell T Sahmoud 2003 Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the atac (arimidex, tamoxifen alone or in combination) trial efficacy and safety update analyses Cancer 98 9 1802 1810 10.1002/cncr.11745 1:CAS:528:DC%2BD3sXpt1arsbc%3D 10.1002/cncr.11745 14584060 (Pubitemid 37310221)
8. B Thurlimann A Keshaviah AS Coates H Mouridsen L Mauriac JF Forbes R Paridaens M Castiglione-Gertsch RD Gelber M Rabaglio I Smith A Wardley KN Price A Goldhirsch 2005 A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer N Engl J Med 353 26 2747 2757 10.1056/NEJMoa052258 10.1056/NEJMoa052258 16382061 (Pubitemid 43016814)
9. C Fontaine A Meulemans M Huizing C Collen L Kaufman J De Mey C Bourgain G Verfaillie J Lamote R Sacre D Schallier B Neyns J Vermorken J De Greve 2008 Tolerance of adjuvant letrozole outside of clinical trials Breast 17 4 376 381 10.1016/j.breast.2008.02.006 1:STN:280:DC%2BD1crgs1Krug%3D%3D 10.1016/j.breast.2008.02.006 18455395
10. Cauley JA, Parimi N, Ensrud KE, Bauer DC, Cawthon PM, Cummings SR, Hoffman AR, Shikany JM, Barrett-Connor E, Orwoll E (2009) Serum 25 hydroxyvitamin d and the risk of hip and non-spine fractures in older men. J Bone Miner Res. doi: 10.1359/jbmr.090826
11. DP Trivedi R Doll KT Khaw 2003 Effect of four monthly oral vitamin d3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial BMJ 326 7387 469 10.1136/bmj.326.7387.469 1:CAS:528:DC%2BD3sXisFart7Y%3D 10.1136/bmj.326. 7387.469 12609940
12. H Smith F Anderson H Raphael P Maslin S Crozier C Cooper 2007 Effect of annual intramuscular vitamin d on fracture risk in elderly men and women-a population-based, randomized, double-blind, placebo-controlled trial Rheumatology (Oxford) 46 12 1852 1857 10.1093/rheumatology/kem240 1:CAS:528:DC%2BD2sXhtlKmtbbF 10.1093/rheumatology/kem240 (Pubitemid 350168304)
13. AM Grant A Avenell MK Campbell AM McDonald GS MacLennan GC McPherson FH Anderson C Cooper RM Francis C Donaldson WJ Gillespie CM Robinson DJ Torgerson WA Wallace 2005 Oral vitamin d3 and calcium for secondary prevention of low-trauma fractures in elderly people (randomised evaluation of calcium or vitamin d, record): a randomised placebo-controlled trial Lancet 365 9471 1621 1628 10.1016/S0140-6736(05)63013-9 1:STN:280:DC%2BD2M3kslClsA%3D%3D 10.1016/S0140-6736(05)63013-9 15885294 (Pubitemid 40693411)
14. MT Cantorna CE Hayes HF DeLuca 1998 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis J Nutr 128 1 68 72 1:CAS:528:DyaK1cXnt1Gluw%3D%3D 9430604
15. HA Bischoff-Ferrari B Dawson-Hughes HB Staehelin JE Orav AE Stuck R Theiler JB Wong A Egli DP Kiel J Henschkowski 2009 Fall prevention with supplemental and active forms of vitamin d: a meta-analysis of randomised controlled trials BMJ 339 b3692 1:STN:280:DC%2BD1Mnmt1Kjsw%3D%3D 10.1136/bmj.b3692 19797342
16. MCE Larrosa A Gomez M Moreno E Berlanga J Ramon J Gratacos 2008 Vitamin d deficiency and related factors in patients with osteoporotic hip fracture Med Clin (Barc) 130 1 4 10.1157/13114538
17. M Vaqueiro M Bare E Anton E Andreu A Moya R Sampere E Villar C Gimeno 2007 hypovitaminosis d associated to low sun exposure in the population over 64 years old Med Clin (Barc) 129 8 287 291 10.1157/13109116 (Pubitemid 47574115)
18. Khan QJ, Reddy PS, Kimler BF, Sharma P, Baxa SE, O'Dea AP, Klemp JR, Fabian CJ (2010) Effect of vitamin d supplementation on serum 25-hydroxy vitamin d levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer. Breast Cancer Res Treat 119(1):111-118. doi: 10.1007/s10549-009-0495-x
19. Nogues X, Servitja S, Pena MJ, Prieto-Alhambra D, Nadal R, Mellibovsky L, Albanell J, Diez-Perez A, Tusquets I (2010) Vitamin d deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer. Maturitas. doi: 10.1016/j.maturitas.2010.03.012
20. NJ Bundred ID Campbell N Davidson RH DeBoer H Eidtmann A Monnier P Neven G von Minckwitz JC Miller NL Schenk RE Coleman 2008 Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: Zo-fast study results Cancer 112 5 1001 1010 10.1002/cncr.23259 1:CAS:528:DC%2BD1cXjs1eqsLs%3D 10.1002/cncr.23259 18205185 (Pubitemid 351304583)
21. DM Reid J Doughty R Eastell SD Heys A Howell EV McCloskey T Powles P Selby RE Coleman 2008 Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK expert group Cancer Treat Rev 34 Suppl 1 S3 S18 10.1016/j.ctrv.2008.03.007 1:CAS:528:DC%2BD1cXmvVOnsrs%3D 10.1016/j.ctrv.2008.03.007 18515009
22. P Hadji JJ Body MS Aapro A Brufsky RE Coleman T Guise A Lipton M Tubiana-Hulin 2008 Practical guidance for the management of aromatase inhibitor-associated bone loss Ann Oncol 19 8 1407 1416 10.1093/annonc/mdn164 1:STN:280:DC%2BD1cvotVOrsA%3D%3D 10.1093/annonc/mdn164 18448451
23. HA Bischoff-Ferrari 2008 Optimal serum 25-hydroxyvitamin d levels for multiple health outcomes Adv Exp Med Biol 624 55 71 1:CAS:528:DC%2BC3cXhtlKisbrN 10.1007/978-0-387-77574-6-5 18348447
24. EP Winer C Hudis HJ Burstein AC Wolff KI Pritchard JN Ingle RT Chlebowski R Gelber SB Edge J Gralow MA Cobleigh EP Mamounas LJ Goldstein TJ Whelan TJ Powles J Bryant C Perkins J Perotti S Braun AS Langer GP Browman MR Somerfield 2005 American society of clinical oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004 J Clin Oncol 23 3 619 629 10.1200/JCO.2005.09.121 1:CAS:528:DC%2BD2MXitVartb4%3D 10.1200/JCO.2005.09.121 15545664 (Pubitemid 46224240)
25. HK Genant CY Wu C van Kuijk MC Nevitt 1993 Vertebral fracture assessment using a semiquantitative technique J Bone Miner Res 8 9 1137 1148 10.1002/jbmr.5650080915 1:STN:280:DyaK2c%2FlsFyhuw%3D%3D 10.1002/jbmr.5650080915 8237484
26. P Orozco Lopez M Zwart Salmeron E Vilert Garrofa C Olmos Dominguez 2004 Prediction of the total calcium intake from consumption of milk products in spain adult population. Indicad study 2001 Aten Primaria 33 5 237 243 1:STN:280:DC%2BD2c3ps1Okuw%3D%3D 10.1157/13059168 15033092 (Pubitemid 38684754)
27. RP Heaney MS Dowell CA Hale A Bendich 2003 Calcium absorption varies within the reference range for serum 25-hydroxyvitamin d J Am Coll Nutr 22 2 142 146 1:CAS:528:DC%2BD3sXjtlelsLw%3D 12672710
28. H Bischoff-Ferrari 2009 Vitamin d: What is an adequate vitamin d level and how much supplementation is necessary? Best Pract Res Clin Rheumatol 23 6 789 795 10.1016/j.berh.2009.09.005 1:CAS:528:DC%2BD1MXhsV2ksLbL 10.1016/j.berh.2009.09.005 19945690
29. KD Crew MD Gammon SE Steck DL Hershman S Cremers E Dworakowski E Shane MB Terry M Desai SL Teitelbaum AI Neugut RM Santella 2009 Association between plasma 25-hydroxyvitamin d and breast cancer risk Cancer Prev Res 2 6 598 604 10.1158/1940-6207.CAPR-08-0138 1:CAS:528:DC%2BC3cXptVWjs74%3D 10.1158/1940-6207.CAPR-08-0138
30. P Lips T Duong A Oleksik D Black S Cummings D Cox T Nickelsen 2001 A global study of vitamin d status and parathyroid function in postmenopausal women with osteoporosis: Baseline data from the multiple outcomes of raloxifene evaluation clinical trial J Clin Endocrinol Metab 86 3 1212 1221 1:CAS:528:DC%2BD3MXitFWnt7s%3D 10.1210/jc.86.3.1212 11238511 (Pubitemid 32323007)
31. O Dizdar L Ozcakar FU Malas H Harputluoglu N Bulut S Aksoy Y Ozisik K Altundag 2009 Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia J Clin Oncol 27 30 4955 4960 10.1200/JCO.2008.20.5435 10.1200/JCO.2008.20.5435 19752344
32. L Morales S Pans K Verschueren B Van Calster R Paridaens R Westhovens D Timmerman L De Smet I Vergote MR Christiaens P Neven 2008 Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome J Clin Oncol 26 19 3147 3152 10.1200/JCO.2007.15.4005 10.1200/JCO.2007.15.4005 18474874
33. RT Chlebowski 2009 Aromatase inhibitor-associated arthralgias J Clin Oncol 27 30 4932 4934 10.1200/JCO.2009.23.3270 10.1200/JCO.2009.23.3270 19752332
34. Waltman NL, Ott CD, Twiss JJ, Gross GJ, Lindsey AM (2009) Vitamin d insufficiency and musculoskeletal symptoms in breast cancer survivors on aromatase inhibitor therapy. Cancer Nurs. doi: 10.1097/01.NCC.0000339262.44560. 92
35. SL Ash BR Goldin 1988 Effects of age and estrogen on renal vitamin d metabolism in the female rat Am J Clin Nutr 47 4 694 699 1:CAS:528: DyaL1cXktVSqurc%3D 3258469
36. Nashold FE, Spach KM, Spanier JA, Hayes CE (2009) Estrogen controls vitamin d3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin d3 metabolism and receptor expression. J Immunol. doi: 10.4049/jimmunol.0901351
37. Y Liel S Shany P Smirnoff B Schwartz 1999 Estrogen increases 1, 25-dihydroxyvitamin d receptors expression and bioresponse in the rat duodenal mucosa Endocrinology 140 1 280 285 1:CAS:528:DyaK1MXhtFWltg%3D%3D 10.1210/en.140.1.280 9886836 (Pubitemid 29011170)
38. K Kinuta H Tanaka T Moriwake K Aya S Kato Y Seino 2000 Vitamin d is an important factor in estrogen biosynthesis of both female and male gonads Endocrinology 141 4 1317 1324 1:CAS:528:DC%2BD3cXisFOktLo%3D 10.1210/en.141.4.1317 10746634 (Pubitemid 32269098)
39. A Enjuanes N Garcia-Giralt A Supervia X Nogues L Mellibovsky J Carbonell D Grinberg S Balcells A Diez-Perez 2003 Regulation of cyp19 gene expression in primary human osteoblasts: effects of vitamin d and other treatments Eur J Endocrinol 148 5 519 526 1:CAS:528:DC%2BD3sXktVGjs7k%3D 10.1530/eje.0.1480519 12720534 (Pubitemid 36622158)
40. MF Holick 2007 Vitamin d deficiency N Engl J Med 357 3 266 281 10.1056/NEJMra070553 1:CAS:528:DC%2BD2sXotVejsbc%3D 10.1056/NEJMra070553 17634462 (Pubitemid 47080391)
41. TT Wang FP Nestel V Bourdeau Y Nagai Q Wang J Liao L Tavera-Mendoza R Lin JW Hanrahan S Mader JH White 2004 Cutting edge: 1, 25-dihydroxyvitamin d3 is a direct inducer of antimicrobial peptide gene expression J Immunol 173 5 2909 2912 1:CAS:528:DC%2BD2cXmvVCrtbw%3D 15322146
42. CD Tsoukas DM Provvedini SC Manolagas 1984 1, 25-dihydroxyvitamin d3: a novel immunoregulatory hormone Science 224 4656 1438 1440 1:CAS:528: DyaL2cXksV2hurw%3D 10.1126/science.6427926 6427926
43. GA Plotnikoff JM Quigley 2003 Prevalence of severe hypovitaminosis d in patients with persistent, nonspecific musculoskeletal pain Mayo Clin Proc 78 12 1463 1470 10.4065/78.12.1463 14661675
44. JG Yague LM Garcia-Segura I Azcoitia 2009 Selective transcriptional regulation of aromatase gene by vitamin d, dexamethasone, and mifepristone in human glioma cells Endocrine 35 2 252 261 10.1007/s12020-008-9134-2 1:CAS:528:DC%2BD1MXpsVCqtLo%3D 10.1007/s12020-008-9134-2 19116788
45. AE Warner SA Arnspiger 2008 Diffuse musculoskeletal pain is not associated with low vitamin d levels or improved by treatment with vitamin d J Clin Rheumatol 14 1 12 16 10.1097/RHU.0b013e31816356a9 10.1097/RHU. 0b013e31816356a9 18431091
46. F Bertoldo S Pancheri S Zenari S Boldini B Giovanazzi M Zanatta MT Valenti LD Carbonare VL Cascio 2009 Serum 25-hydroxyvitamin d levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion J Bone Miner Res 25 3 447 454 10.1359/jbmr.090819 10.1359/jbmr.090819
47. HJ Burstein 2007 Aromatase inhibitor-associated arthralgia syndrome Breast 16 3 223 234 10.1016/j.breast.2007.01.011 10.1016/j.breast.2007.01.011 17368903 (Pubitemid 46796859)
48. Avenell A, Gillespie WJ, Gillespie LD, O'Connell D (2009) Vitamin d and vitamin d analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev (2):CD000227. doi: 10.1002/14651858.CD000227.pub3
49. MJ Bolland A Grey IR Reid 2009 Time for a moratorium on vitamin d meta-analyses? BMJ 339 b4394 10.1136/bmj.b4394 19864356
50. Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D'Erasmo E, Carnevale V, Scillitani A, Minisola S (2008) Short and long term variations in serum calciotrophic hormones after a single very large dose of ergocalciferol (vitamin d2) or cholecalciferol (vitamin d3) in the elderly. J Clin Endocrinol Metab. doi: 10.1210/jc.2008-0350
51. MO Premaor R Scalco MJ da Silva PE Froehlich TW Furlanetto 2008 The effect of a single dose versus a daily dose of cholecalciferol on the serum 25-hydroxycholecalciferol and parathyroid hormone levels in the elderly with secondary hyperparathyroidism living in a low-income housing unit J Bone Miner Metab 26 6 603 608 10.1007/s00774-008-0858-0 1:CAS:528:DC%2BD1cXhtlWhtb%2FP 10.1007/s00774-008-0858-0 18979160
52. Leventis P, Kiely PD (2008) The tolerability and biochemical effects of high-dose bolus vitamin d2 and d3 supplementation in patients with vitamin d insufficiency. Scand J Rheumatol 38:149-153. doi: 10.1080/03009740802419081
53. Bacon CJ, Gamble GD, Horne AM, Scott MA, Reid IR (2008) High-dose oral vitamin d(3) supplementation in the elderly. Osteoporos Int. doi: 10.1007/s00198-008-0814-9
54. KM Sanders AL Stuart EJ Williamson JA Simpson MA Kotowicz D Young GC Nicholson 2010 Annual high-dose oral vitamin d and falls and fractures in older women: a randomized controlled trial JAMA 303 18 1815 1822 10.1001/jama.2010.594 1:CAS:528:DC%2BC3cXmtV2hsLs%3D 10.1001/jama.2010.594 20460620
55. Priemel M, von Domarus C, Klatte TO, Kessler S, Schlie J, Meier S, Proksch N, Pastor F, Netter C, Streichert T, Puschel K, Amling M (2009) Bone mineralization defects and vitamin d deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin d in 675 patients. J Bone Miner Res. doi: 10.1359/jbmr.090728